Genedrive (GB:GDR) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Genedrive PLC has released its 2024 Annual Report and announced the upcoming Annual General Meeting on December 30, 2024. The company, a leader in pharmacogenetic testing, continues to innovate with its Genedrive® MT-RNR1 and CYP2C19 ID Kits, enhancing personalized medicine and improving patient outcomes in emergency care. The company is focused on growth through market expansion and strategic acquisitions.
For further insights into GB:GDR stock, check out TipRanks’ Stock Analysis page.
Trending Articles
- Oppenheimer Pounds the Table on Coinbase Stock
- New “Anti-Woke” ETF Targets Starbucks (NASDAQ:SBUX)
- Ford (NYSE:F) Plans New EV Plant
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
